France begins trials of new COVID vaccine
Other countries
- 25 February, 2021
- 06:11
Add Report.az to preferred Google sources
Stay up to date with the top news!
French biotechnology company Xenothera has begun clinical trials of its coronavirus vaccine, Report informs with reference to TASS.
The vaccine is named Xav-19.
The vaccine testing program follows Polycor standards, one of 15 types of clinical trials of drugs approved by the French medical authorities. The trial will be carried out in 40 hospitals in the country, coordinated by the University Hospital of Nantes.
The drug will be tested on 400 volunteer patients. Currently, 67 patients from 21 hospitals are participating in the trial.
The tests are supposed to determine the level of vaccine effectiveness with great accuracy.
Latest News
00:04
80 people suffer food poisoning in Türkiye's Izmir
Region
23:40
UK ambassador summoned to Iranian Foreign Ministry over RAF Fairford claims
Region
23:06
Photo
Sabah beat Slavia 2-0 for historic Champions League victory
Football
22:46
Marta Kos: Albania's EU membership by 2030 is entirely possible
Other countries
22:25
Netherlands may need €9.5 billion to upgrade roads and railways for NATO
Other countries
22:12
Photo
Video
Sites of Memory of Western Azerbaijan: History of Arafsa in Zangazur
Domestic policy
21:54
Photo
Nakhchivan, ADB discuss Zangazur Corridor and regional projects
Tourism
21:27
Azerbaijani ambassador highlights energy cooperation with EU at Zagreb forum
Foreign policy
21:14
Mikayil Jabbarov highlights Azerbaijan-Turkmenistan role in Middle Corridor
Foreign policy